110 related articles for article (PubMed ID: 10487004)
1. Immunohistochemical study of ACTH and alpha-MSH in vitiligo patients successfully treated with a sex steroid-thyroid hormone mixture.
Ichimiya M
J Dermatol; 1999 Aug; 26(8):502-6. PubMed ID: 10487004
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of vitiligo with a sex steroid-thyroid hormone mixture.
Muto M; Furumoto H; Ohmura A; Asagami C
J Dermatol; 1995 Oct; 22(10):770-2. PubMed ID: 8586759
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of non-segmental vitiligo: systemic therapy with sex hormone-thyroid powder mixture.
Nagai K; Ichimiya M; Yokoyama K; Hamamoto Y; Muto M
Horm Res; 2000; 54(5-6):316-7. PubMed ID: 11595825
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effects of metharmon F for postmenopausal women with climacteric symptoms: its relationship with serum level of hormones].
Yoshimoto S; Fujita T
Horumon To Rinsho; 1983 Aug; 31(8):815-22. PubMed ID: 6414748
[No Abstract] [Full Text] [Related]
5. [Metharmon F for glossalgia caused by autonomic dysfunction].
Densho S; Ohama G; Yamamoto E; Komatsu Y; Genba R
Shikai Tenbo; 1985 Aug; 66(2):455-60. PubMed ID: 3866331
[No Abstract] [Full Text] [Related]
6. [The effect of estrogen and, sex-steroids and thyroid hormone preparation on bone mineral density in senile osteoporosis--a comparative study of the effect of 1 alpha-hydroxycholecalciferol (1 alpha-OHD3) on senile osteoporosis].
Shiraki M; Orimo H
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):84-95. PubMed ID: 1645679
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor.
Wakamatsu K; Graham A; Cook D; Thody AJ
Pigment Cell Res; 1997 Oct; 10(5):288-97. PubMed ID: 9359624
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin expression by human melanocytes in the skin.
Iyengar B
Pigment Cell Res; 1995 Jun; 8(3):142-6. PubMed ID: 7567790
[TBL] [Abstract][Full Text] [Related]
9. Novel approaches to vitiligo treatment via modulation of mTOR and NF-κB pathways in human skin melanocytes.
Wan J; Lin F; Zhang W; Xu A; DeGiorgis J; Lu H; Wan Y
Int J Biol Sci; 2017; 13(3):391-400. PubMed ID: 28367103
[TBL] [Abstract][Full Text] [Related]
10. ACTH acts directly on melanocytes to stimulate melanogenesis--an in vitro study.
Iyengar B; Misra RS; Subalakshmi
Indian J Pathol Microbiol; 1995 Oct; 38(4):399-402. PubMed ID: 9726151
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides.
Moustafa M; Szabo M; Ghanem GE; Morandini R; Kemp EH; MacNeil S; Haycock JW
J Invest Dermatol; 2002 Dec; 119(6):1244-53. PubMed ID: 12485424
[TBL] [Abstract][Full Text] [Related]
12. The expression of alpha-MSH by melanocytes is reduced in vitiligo.
Graham A; Westerhof W; Thody AJ
Ann N Y Acad Sci; 1999 Oct; 885():470-3. PubMed ID: 10816691
[No Abstract] [Full Text] [Related]
13. Silk Fibroin-Based Hydrogel Microneedles Deliver α-MSH to Promote Melanosome Delivery for Vitiligo Treatment.
Chong S; Wei C; Feng L; Guo R
ACS Biomater Sci Eng; 2023 Jun; 9(6):3368-3378. PubMed ID: 37115665
[TBL] [Abstract][Full Text] [Related]
14. Tofacitinib combined with melanocyte protector α-MSH to treat vitiligo through dextran based hydrogel microneedles.
Liang J; Yu Y; Li C; Li Q; Chen P; Li W; Liu W; Li Z; Liu Y; Zhang S; Zhang X
Carbohydr Polym; 2023 Apr; 305():120549. PubMed ID: 36737198
[TBL] [Abstract][Full Text] [Related]
15. Eumelanin and phaeomelanin contents of depigmented and repigmented skin in vitiligo patients.
Parsad D; Wakamatsu K; Kanwar AJ; Kumar B; Ito S
Br J Dermatol; 2003 Sep; 149(3):624-6. PubMed ID: 14510999
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo.
Spencer JD; Gibbons NC; Rokos H; Peters EM; Wood JM; Schallreuter KU
J Invest Dermatol; 2007 Feb; 127(2):411-20. PubMed ID: 16946714
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone in alopecia areata.
Kim HS; Cho DH; Kim HJ; Lee JY; Cho BK; Park HJ
Exp Dermatol; 2006 Jul; 15(7):515-22. PubMed ID: 16761960
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan-A marker.
Kubanov A; Proshutinskaia D; Volnukhin V; Katunina O; Abramova T
Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):5-9. PubMed ID: 27014772
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.
Grimes PE; Hamzavi I; Lebwohl M; Ortonne JP; Lim HW
JAMA Dermatol; 2013 Jan; 149(1):68-73. PubMed ID: 23407924
[TBL] [Abstract][Full Text] [Related]
20. ACTH stimulates melanogenesis in cultured human melanocytes.
Hunt G; Todd C; Kyne S; Thody AJ
J Endocrinol; 1994 Jan; 140(1):R1-3. PubMed ID: 8138743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
